… A randomized study in patients with locally advanced squamous cell cancer of the head
and neck compared the combination of cetuximab and radiation therapy (211 patients) with …

… and neck cancer. For these reasons, we conducted a randomized, phase 3 … cetuximab to
radiotherapy in the treatment of patients with locoregionally advanced head and neck cancer. …

… This study provided proof of principle for the activity of cetuximab with radiation and in
squamous cell cancer of the head and neck. It also provides a step forward in care for patients …

… , as is cetuximab monotherapy. When cetuximab is added to cisplatin monotherapy in the
first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck, …

… Phase I study of antiepidermal growth factor receptor antibody cetuximab in combination with
radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 2001 Jul 1; …

… head and neck cancers are squamous cell carcinomas, which commonly overexpress the
EGF receptor (EGFR). Cetuximab … advanced squamous cell carcinoma of the head and neck, …

Purpose This was an open, randomized, multicenter, phase I/II study to investigate the safety
and tolerability of cetuximab in the first-line treatment of recurrent/metastatic squamous cell …

… squamous cell carcinomas of the head and neck (SCCHN); this overexpression is associated
with more aggressive disease and poorer prognosis. In the EU, cetuximab is … Head Neck …

… receptor (EGFR) inhibitor cetuximab is active in recurrent and/or metastatic squamous cell
carcinoma of the head and neck (SCCHN). The activity of cetuximab was compared with that …

… aggressive growth in cancer, EGFR is a valid target for the treatment of cancer patients, …
-targeted therapy with cetuximab in selected head and neck squamous cell carcinoma is not …